Kairos Pharma Ltd. (KAPA)
0.85
-0.02
(-2.83%)
USD |
NYAM |
Jan 21, 16:00
0.78
-0.07
(-8.24%)
After-Hours: 20:00
Kairos Pharma EPS Diluted (Quarterly): -0.0692 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.398M |
| Total Expenses (Quarterly) | 1.398M |
| Enterprise Value | 12.12M |
| Earnings Yield | -35.60% |
| Normalized Earnings Yield | -38.54 |